Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(2.65) per share which missed the analyst consensus estimate of $(1.39) by 90.65 percent. This is a 14.52 percent increase over losses of $(3.10) per share from the same period last year. The company reported quarterly sales of $33.562 million which beat the analyst consensus estimate of $32.961 million by 1.82 percent. This is a 0.61 percent increase over sales of $33.358 million the same period last year.